Icosapent Disease Interactions
There are 2 disease interactions with icosapent.
Icosapent (applies to icosapent) atrial fibrillation/flutter
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Arrhythmias
Icosapent is associated with an increased risk of atrial fibrillation or atrial flutter requiring hospitalization. In a cardiovascular outcomes trial, the incidence of atrial fibrillation was greater in patients with history of atrial fibrillation or atrial flutter; caution is recommended in these patients.
References
- (2019) "Product Information. Vascepa (icosapent)." Amarin Pharmaceuticals Inc, SUPPL-35
Icosapent (applies to icosapent) liver disease
Moderate Potential Hazard, Moderate plausibility.
In patients with liver dysfunction, ALT and AST levels should be monitored periodically during therapy with icosapent; caution is recommended in these patients.
References
- (2019) "Product Information. Vascepa (icosapent)." Amarin Pharmaceuticals Inc, SUPPL-35
Icosapent drug interactions
There are 72 drug interactions with icosapent.
More about icosapent
- icosapent consumer information
- Check interactions
- Compare alternatives
- Reviews (125)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.